Edition:
United Kingdom

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

28.40CAD
23 May 2018
Change (% chg)

$0.16 (+0.57%)
Prev Close
$28.24
Open
$28.01
Day's High
$28.49
Day's Low
$27.87
Volume
1,149,126
Avg. Vol
1,402,626
52-wk High
$30.56
52-wk Low
$14.01

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Joseph Papa

62 2016 Chairman of the Board, Chief Executive Officer

Paul Herendeen

62 2016 Chief Financial Officer, Executive Vice President

Christina Ackermann

53 2016 Executive Vice President, General Counsel

Thomas Appio

56 2016 Executive Vice President, Company Group Chairman, International

William Humphries

51 2017 Executive Vice President, Company Group Chairman, Dermatology